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Drug carriers such as liposomes are not readily transported across cellular barriers that constitute epithelia. However, 
certain epithelia (rabbit yolk sac endoderm and enterocytes of suckling rat gut proximal small intestine) are well known 
to transcytose maternal IgG by Fc receptor-mediated endocytic events. We have shown that coating liposomes with ap- 
propriate IgG enhances their transport across these epithelia, as measured both by radioactivity indicative of liposomal 
membrane or entrapped iz51-PVP and rH]inulin, and by the hypoglycemic effect of entrapped insulin. It is suggested 
that these transported liposomes follow a pathway of transcytosis in clathrin-coated vesicles, thus escaping lysosomal 
degradation. 
Liposome; Epithelium; Transcytosis; Immunoglobulin G 
1. INTRODUCTION 
In recent years a number of drug carriers 
(liposomes, nanoparticles and microspheres) have 
been developed in order to improve target 
specificity and reduce toxicity of drugs used in 
chemotherapy. One of the major problems with 
these carriers is that they are not transported readi- 
ly across cellular barriers, in particular epithelial 
cells lining the gut. Various investigators have 
shown that biodegradable substances like insulin 
or factor VIII entrapped in liposomes are 
transported across the mammalian gut [l-4] but 
the liposomes themselves are not transcytosed 
[4,5]. Although intact liposomes are taken up by 
the epithelial cells they are degraded intracellular- 
ly, thus releasing the entrapped drug of which only 
a small amount escapes intracellular digestion and 
is eventually transported across the cell into the 
blood circulation [5]. 
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Certain epithelia, as constituted by human 
placental syncytiotrophoblast, rabbit yolk sac en- 
doderm and enterocytes of suckling rodent prox- 
imal small intestine, are well known to transcytose 
IgG derived from maternal blood, uterine fluid, 
and colostrum and milk, respectively [6]. 
Transport of IgG is highly selective and depends 
on the species of origin of the IgG. The transport 
mechanism involves binding of IgG to Fc receptors 
present on the epithelial cells followed by receptor- 
mediated endocytic events and eventually 
transcytosis in clathrin-coated vesicles [7,8]. 
Various studies [9,10] have indicated that 
liposomes coated with antibodies are taken up 
more readily by cells expressing Fc receptors (e.g. 
macrophages and lymphocytes) but there have 
been no investigations to show the possibility of 
specific receptor-mediated transcytosis of intact 
carriers across epithelial cells. We have, therefore, 
examined the possibility that IgG itself can act as 
a carrier of liposomes by causing their transcytosis 
across the yolk sac into the blood of the foetal rab- 
bit and across the gut into the blood of the suckling 
rat. Our initial experiments provide encouraging 
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data in this respect and suggest hat these epithelial 
barriers could be used as model systems for the 
analysis of similar transport processes in other 
types of cells. 
2. MATERIALS AND METHODS 
Negatively charged small unilamellar liposomes containing 
‘zsI-polyvinylpyrrolidone (PVP) of molecular mass 40-60 kDa, 
[3H]inulin or ox pancreas insulin (from Wellcome) were 
prepared as described earlier [5]. For use in the suckling rat ex- 
periments (see below) IgG was covalently coupled to liposomes 
by the method described by Leserman et al. [l l] and for the 
pregnant rabbit experiments, IgG was nonspecifically attached 
onto liposomes by the sonication method [12]. Liposomal mem- 
branes were labelled with cholesteryl-[r4C]oleate as described by 
Kao and Juliano 1131. 
New Zealand white rabbits at 24-26 days of pregnancy and 
Wistar suckling rats 12-22 days old were used. Rabbits were 
operated on using nembutal/ether anaesthesia .and after 
laparotomy, the exposed uterine horns were ligated so as to 
isolate each individual conceptus; 1 ml of liposomes (= 20 mg 
lipid) or other test material was injected into the uterine lumen 
between each ligature. The uterine horns were replaced into the 
abdominal cavity, the incisions closed, and the rabbits allowed 
to recover for 4 h before being given a lethal injection of nem- 
butal into the marginal ear vein. Each conceptus was then 
removed from the uterine lumen by detachment of the placenta 
basalis. The yolk sac was dissected free, washed in saline to 
remove adherent debris and the paraplacental chorion trimmed 
away; amniotic fluid and foetal heart blood were also collected. 
Radioactivity was counted in appropriate aliquots of tissue and 
fluids and expressed as a concentration quotient (CQ) as shown 
in the results. 
Suckling rats were isolated from the mother 1 h prior to 
feeding 0.5 ml (= 30 mg lipid) of liposomes or other test 
material by stomach tube. After 3 h, blood, liver and kidneys 
were removed and the radioactivity of the injected substances 
was measured. The glucose concentration in the blood was 
measured by the method described previously [I]. 
3. RESULTS 
The results in table 1 show that when 1251-PVP 
is injected into the uterine lumen of the pregnant 
rabbit in liposomal form it is subsequently 
transported into fetal blood and amniotic fluid 
more readily than when given in the free form. 
Transport was considerably enhanced, particularly 
to the blood, when liposomes were coated with 
human IgG. However, when liposomes were 
coated with bovine IgG, this enhancing effect of 
IgG on the transport of “‘1-PVP entrapped in 
liposomes was reduced to only 10% in the blood 
and 33% in the amniotic fluid when compared 
with results obtained for human IgG-coated 
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Table 1 
Transport of “*I-PVP across rabbit yolk sac endoderm 
expressed as concentration quotients (CQs) 
‘z51-PvP ‘251-PVP radioactivity 
administered 
CQ” 
cpm/ml or g tissue 
= ---~- 
total ‘*‘I-PVP cpm injected’ lo-“) 
Yolk sac Amniotic 
fluid 
Fetal 
blood 
Free 
Liposomes 
Human IgG- 
liposomes 
Bovine IgG- 
liposomes 
4.40 f 0.7 0.29 i 0.08 0.07 +- 0.02 
6.00 T 0.6 2.70 + 0.8 3.40 * 1.5 
32.00 + 5.0 18.50 + 1.2 61.00 + 1.4 
25.60 + 3.0 6.50 + 0.9 6.00 + 0.7 
a Mean f SE of 4 to 5 conceptuses 
liposomes. The amount of radioactivity still re- 
tained in the yolk sac was greatest for ‘251-PVP en- 
trapped in human IgG-coated liposomes but 
coating with bovine IgG, as opposed to no coating, 
or administration in free form, also caused much 
more uptake of PVP. Comparison of the CQs for 
the radioactivity in the blood and the yolk sac 
reveals that in the case of human IgG-coated 
liposomes nearly twice as much radioactivity 
reaches the blood as is retained in the yolk sac. In 
the case of bovine IgG-coated liposomes however, 
the situation is reversed, with almost four times the 
amount of radioactivity being retained in the yolk 
sac as is transported to the bIood. 
That the enhanced transport of PVP entrapped 
in liposomes coated with human IgG is a conse- 
quence of liposome uptake and transport as such, 
and not some other process, is indicated by the 
results shown in table 2. Here the liposomal mem- 
branes were labelled by incorporation of 
cholesteryl-[‘4C]oleate, and it is clear that much 
more liposomal material has been taken up into the 
yolk sac and transported to the fetal blood when 
coated with human IgG than when Iiposomes were 
uncoated. Indeed, similar values for the CQs are 
apparent when comparison is made between results 
in tables 1 and 2, even though different compart- 
ments of the liposomes have been labelled. 
The results in table 3 show that the transport of 
liposomally entrapped [3H]inulin is greater than 
for the free substance when administered in- 
tragastrically to suckling rats. Covalent attach- 
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Table 2 Table 4 
Transport of liposomes labelled with lipid marker, cholesteryl- 
[‘%Z]oleate, across rabbit yolk sac endoderm expressed as 
concentration quotient (CQ) 
Effect of intragastrically administered insulin on blood glucose 
level in 12-, 17- and 22-day-old suckling rats 
Preparation aBlood glucose concentration 
(o/o of the initial value) Preparation Cho1esteryl-[‘4C]oleate radioactivity 
fcoa = 
cpm/ml or g tissue 
x lo- 3\ 
\ - total cpm injected / 
Yolk sac Amniotic Fetal 
fluid blood 
Liposomes 
Human IgG- 
liposomes 
5.0 + 1.2 2.9 & 0.8 6.8 f 2.2 
38.0 + 4.0 22.0 * 1.0 64.0 + 3.0 
a Mean k SE of 5 conceptuses 
ment of rat IgG onto liposomes containing 
[3H]inulin almost doubled the transport of [3H]in- 
ulin into the blood and when free rat IgG was ad- 
ministered together with IgG-coated liposomes, 
inhibition of transport of radioactivity was ob- 
served. Some of the absorbed radioactivity became 
localised in liver and kidney and more so when ad- 
ministered in liposomes than in free form. Results 
similar to these were obtained when transport of 
‘251-PVP, either free, entrapped in liposomes, or 
entrapped in liposomes coated with IgG, was ad- 
ministered to suckling rats (not shown). 
The results in table 4 show that when 2.5 mU of 
insulin entrapped in rat IgG-coated liposomes was 
administered intragastrically to suckling rats of 
Table 3 
Absorption of intragastrically administered [‘Hlinulin in 
12-day-old suckling rats 
Preparation [‘H]Inulin radioactivity 
(070 of the dosea) 
Bloodb Liver Kidney 
Empty liposomes + 
[3H]inulin 1.37 + 0.2 1.57 + 0.1 0.83 f 0.1 
Liposomal [3H]inu1in 2.77 + 0.7 2.64 + 0.4 1.65 + 0.1 
Rat IgG-coated lipo- 
somal [3H]inulin 5.39 +_ 0.5 2.79 + 0.2 1.46 k 0.2 
Free rat IgG + IgG- 
coated liposomal 
13H]inu1in 3.40 f 0.4 2.32 + 0.3 1.51 + 0.3 
a Mean + SE of 5 rats 
b % per ml of blood, or % per whole organ 
Age: 12 days 17 days 22 days 
Free insulin + lipids (5 U) 105 + 7 101 + 8 103 + 7 
Insulin in liposomes 
(5.5 mu) 
Insulin in rat IgG-coated 
87 + 3 94 f 6 93 * 5 
liposome (2.5 mu) 
a Mean + SE of 7 animals 
67 f 4 79 + 4 95 * 7 
different age groups, a significant reduction in 
blood glucose level occurred in those at 12 and 17 
days but no change occurred in those at 22 days. 
On the other hand, 5.5 mU of insulin in non-IgG- 
coated liposomes produced no significant change 
in blood glucose levels in any of the rats except for 
a small reduction at 12 days. Insulin in free form 
given in a dose as large as 5 U did not reduce the 
blood glucose level in any animals at any of the 
three ages. 
4. DISCUSSION 
Our results show that transport of the non- 
degradable molecules 1251-PVP and [3H]inulin to 
the blood of the fetal rabbit and suckling rat across 
epithelial barriers, constituted by yolk sac en- 
doderm and gut enterocytes, is enhanced when 
these substances are incorporated into liposomes 
compared to presenting them to cells in their free 
form. Such transport is further increased (18-fold 
for ‘251-PVP across the yolk sac and almost dou- 
bled for [3H]inulin across the gut) when ap- 
propriate IgG is either non-specifically attached or 
covalently linked to the liposome surface. That the 
transcytosis of IgG-coated liposomes is probably 
Fc-receptor mediated, is supported by several ob- 
servations emerging from our results. Firstly, 
coating liposomes with bovine IgG, whilst en- 
hancing the uptake of liposomes as indicated by 
the entrapped ‘251-PVP, led to much less transport 
across the yolk sac endoderm to the fetal blood 
compared to coating with human IgG. It is known 
that bovine IgG is readily endocytosed by yolk sac 
endoderm, but unlike human IgG is poorly 
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transported to the blood [ 141 and binds less readily 
to Fc receptors detected on isolated endodermal 
cells in rosette assays [ 15,161. Secondly, it was 
found that co-administration of free rat IgG with 
IgG-coated liposomes produced competitive in- 
hibition in the transport of entrapped [3H]inulin 
across the gut wall of the suckling rat and which 
can be interpreted as competition for binding to 
receptors. Thirdly, we found that insulin en- 
trapped in IgG-coated liposomes produced hypo- 
glycemic effects in 12- and 17-day-old suckling 
rats, but not in those at 22 days. After 21 days of 
age the suckling rat is known not to transport IgG 
across the gut wall to the blood circulation [ 171 and 
beyond this age Fc receptors can no longer be 
detected on gut enterocytes as shown by a variety 
of assays [l&20]. 
An important question to be answered is 
whether liposomes were endocytosed and trans- 
ported intact across the epithelial cells. Evidence 
that this is the case is suggested by the similar CQs 
obtained when cholesteryl-[‘4C]oleate was used as 
a non-exchangeable liposomal membrane marker 
[13] and ‘251-PVP was entrapped in liposomes. 
Where entry of liposomes into yolk sac endoder- 
ma1 cells has taken place by other means, for ex- 
ample membrane fusion, such similar exiting of 
the different markers into the fetal blood and ac- 
cumulation within the cells, would not have been 
expected. Furthermore, free [3H]inulin and 1251- 
PVP have very short half-lives in the blood [21] 
and the relatively high radioactivities found in this 
compartment at the end of our experiments suggest 
that intact liposomes are indeed present. The 
hypoglycemic effect produced in suckling rats by a 
much smaller dose of insulin entrapped in IgG- 
coated liposomes, provides further evidence that 
IgG-coated liposomes escape intracellular diges- 
tion and are transported intact into the circulation. 
Liposomes containing entrapped insulin have 
previously been shown to be more effective than 
free insulin in_that they produce more prolonged 
and greater hypoglycemic effect when injected sub- 
cutaneously into rats and dogs [22]. 
We can only conjecture as to how IgG-coated 
liposomes escape digestion during their transcyto- 
sis. Transport of IgG across rabbit yolk sac en- 
doderm involves selective events thought to take 
place at the cell surface [23] and in which IgG 
destined for transport is transcytosed in clathrin- 
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coated vesicles bound to Fc receptors, whilst IgG 
destined for proteolysis is carried in endosomes 
which fuse with lysosomes. Transport of IgG 
across suckling rat gut takes place in the 
duodenum and jejunum by a similar mechanism 
except that selection has also been shown to occur 
in apical vesicles [8]. Very little or no free 1251-PVP 
is transcytosed across yolk sac endoderm and gut 
enterocytes as shown in previous studies [24,25] 
and the present investigations; it merely enters the 
cells through fluid phase endocytosis and ac- 
cumulates undegraded in phagolysosomes. A 
similar route probably is followed by [3H]inulin 
but the enhanced transport of these molecules 
following entrapment in liposomes might reflect 
some degree of non-specific transcytosis in the 
coated vesicle pathway. By coating liposomes with 
human and rat IgG, a greater proportion of them 
might be expected to enter the coated vesicle 
pathway through specific binding to Fc receptors, 
which would explain why so much more ‘*‘I-PVP, 
[3H]inulin, or insulin (as deduced from its 
hypoglycemic effect) traverses the epithelial bar- 
riers. Coating liposomes with IgG might also be ex- 
pected to increase ‘non-selective’ uptake into the 
endosome system through interaction with less 
specific binding sites on the apical plasma mem- 
brane and therefore greater accumulation in 
phagolysosomes. This would explain the increased 
radioactivity found in the yolk sac when liposomes 
were also coated with bovine IgG. 
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